News for Sino Biopharmaceutical Limited (SBMFF)

Sino Biopharmaceutical Ltd (SBMFF), a leading pharmaceutical company in China, announced its audited financial results for the year ending December 31, 2024. Th

- Dual Success of Innovative Drugs and Generic Drugs- Revenue Recorded RMB28.87 Billion- Adjusted non-HKFRS Profit Attributable to the Owners of the Parent Reco

Sino Biopharmaceutical Limited (SBHMY) declares $0.0653/share quarterly dividend, payable Oct. 18 for shareholders of record Sept. 12.

Exploring the Dividend Performance and Sustainability of Sino Biopharmaceutical Ltd (SBMFF) Sino Biopharmaceutical Ltd (SBMFF) has recently declared a dividend

6 June 2024Worldwide Healthcare Trust PLC ...

At least 11 generic versions of Novo Nordisk's popular diabetes drug Ozempic are in the final stages of clinical trials in China, as developers seek to profit from an early patent expiry of...

Sino Biopharm (1177.HK) Announces 2023 Annual Results

Enhancing Cancer Patients' Quality of Life: Cancer Chemotherapy-Associated Nausea and Vomiting Therapeutics Market Offers Innovative Solutions to Alleviate...

Strong sales fully demonstrated Akeso's commercialization ability: Products sales totaled RMB1,104.4 million, increasing 422% .开坦尼® (cadonilimab) recorded...

Current national security tensions could put F-star's acquisition by Sino Biopharmaceutical at significant risk. Here's what investors in FSTX stock need to know.

FSTX seems undervalued, even at the $7.12 takeover bid. CFIUS is delaying the closure of the deal, citing review needed to allay US national security concerns. Read more here.

LONDON, Jan. 26, 2023 (GLOBE NEWSWIRE) -- invoX Pharma (“invoX”), a wholly owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX...

/PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso"), a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and...

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ... | December 29, 2022

Aktieägarna i Karolinska Development AB (publ), org.nr 556707-5048, (“Karolinska Development” eller “Bolaget”), kallas till årsstämma torsdagen den 12 maj...

/PRNewswire/ -- Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the...

HONG KONG, Nov. 23, 2021 /PRNewswire/ -- Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong T...

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its... | February 23, 2021